FDA Inspection 1031191 — Paradox Inc

Paradox Inc — FEI 1927976

The FDA completed an inspection of Paradox Inc on November 6, 2017 in Saint Joseph, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 6, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Saint Joseph, MO (United States)